Given the significant insider selling activity and ongoing DOJ investigations into Inari Medical’s alleged illegal practices, I anticipate further dec...
Read
More
Given the significant insider selling activity and ongoing DOJ investigations into Inari Medical’s alleged illegal practices, I anticipate further declines in the stock price. Therefore, I see NARI as a potential short opportunity as the negative sentiment surrounding the company is likely to persist in the near term.
With Stryker in the final stages of acquiring Inari Medical, I've got my eyes on NARI. The immediate reaction to this acquisition news and the expecte...
Read
More
With Stryker in the final stages of acquiring Inari Medical, I've got my eyes on NARI. The immediate reaction to this acquisition news and the expected upward movement could lead to a good profit as the acquisition deal closes at $80/share, which means great upside potential for NARI in the near term.